In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.

Under the revised agreement, the two have taken their RSV commitment a step forward as Zhifei agrees to engage exclusively ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK said on Thursday it has expanded its agreement with China's Zhifei to explore a collaboration with the Chinese vaccines ...

GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.

UK pharma major GSK has into an agreement with Chongqing Zhifei Biological Products (Zhifei) to revize the terms on which ...

Big pharma company GSK and UK AI-biotech Relation Therapeutics have entered into two strategic collaborations to identify and ...

Relation has announced two strategic collaborations with GSK, focusing on new therapeutics for fibrotic and osteoarthritis.

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

Relation Therapeutics and GSK signed two contracts to discover and develop new therapeutic targets to treat osteoarthritis and fibrotic disease.

Muna may also receive tiered royalties from sales of any products that come from the collaboration ... broader Alzheimer's ...